company background image
ANGO logo

AngioDynamics NasdaqGS:ANGO Stock Report

Last Price

US$6.95

Market Cap

US$296.4m

7D

13.4%

1Y

-20.5%

Updated

18 Jul, 2024

Data

Company Financials +

AngioDynamics, Inc.

NasdaqGS:ANGO Stock Report

Market Cap: US$296.4m

ANGO Stock Overview

Provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally.

ANGO fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health6/6
Dividends0/6

AngioDynamics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AngioDynamics
Historical stock prices
Current Share PriceUS$6.95
52 Week HighUS$9.43
52 Week LowUS$5.26
Beta0.66
11 Month Change23.01%
3 Month Change11.02%
1 Year Change-20.48%
33 Year Change-73.28%
5 Year Change-66.87%
Change since IPO-44.40%

Recent News & Updates

AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Jul 19
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

Jul 18
Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

Recent updates

AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Jul 19
AngioDynamics, Inc. (NASDAQ:ANGO) Just Released Its Annual Results And Analysts Are Updating Their Estimates

Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

Jul 18
Improved Revenues Required Before AngioDynamics, Inc. (NASDAQ:ANGO) Stock's 26% Jump Looks Justified

AngioDynamics: A Story To Monitor

May 14

A Leaner AngioDynamics Is A High-Risk Execution-Driven Story

Apr 09

AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

Apr 06
AngioDynamics, Inc.'s (NASDAQ:ANGO) Shares Bounce 26% But Its Business Still Trails The Industry

AngioDynamics: Restructuring Initiative May Not Go Far Enough

Jan 14

AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Oct 12
AngioDynamics (NASDAQ:ANGO) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

Mar 31
AngioDynamics (NASDAQ:ANGO) Is Carrying A Fair Bit Of Debt

AngioDynamics Non-GAAP EPS of -$0.06 misses by $0.04, revenue of $81.5M misses by $1.93M, reaffirms FY guidance

Oct 06

AngioDynamics: Lack Of Upside Capture Remains, Continue To Hold

Sep 29

Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

Sep 02
Is AngioDynamics (NASDAQ:ANGO) Using Debt In A Risky Way?

AngioDynamics Non-GAAP EPS of $0.01 in-line, revenue of $87M beats by $4.09M

Jul 12

AngioDynamics Shows Progress In Still-Challenging Times

Apr 08

Is AngioDynamics (NASDAQ:ANGO) Using Debt Sensibly?

Apr 08
Is AngioDynamics (NASDAQ:ANGO) Using Debt Sensibly?

AngioDynamics - Progress Despite Margin And Pandemic Challenges

Feb 01

Shareholder Returns

ANGOUS Medical EquipmentUS Market
7D13.4%-1.5%-0.7%
1Y-20.5%-4.0%20.2%

Return vs Industry: ANGO underperformed the US Medical Equipment industry which returned -0.5% over the past year.

Return vs Market: ANGO underperformed the US Market which returned 20.5% over the past year.

Price Volatility

Is ANGO's price volatile compared to industry and market?
ANGO volatility
ANGO Average Weekly Movement10.2%
Medical Equipment Industry Average Movement8.0%
Market Average Movement5.9%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: ANGO has not had significant price volatility in the past 3 months.

Volatility Over Time: ANGO's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1988815Jim Clemmerwww.angiodynamics.com

AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company’s thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure.

AngioDynamics, Inc. Fundamentals Summary

How do AngioDynamics's earnings and revenue compare to its market cap?
ANGO fundamental statistics
Market capUS$296.40m
Earnings (TTM)-US$184.35m
Revenue (TTM)US$303.91m

0.9x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ANGO income statement (TTM)
RevenueUS$303.91m
Cost of RevenueUS$149.22m
Gross ProfitUS$154.70m
Other ExpensesUS$339.05m
Earnings-US$184.35m

Last Reported Earnings

May 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-4.60
Gross Margin50.90%
Net Profit Margin-60.66%
Debt/Equity Ratio0%

How did ANGO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.